Cigarette Smoking Decision Study
2 other identifiers
interventional
37
1 country
1
Brief Summary
The Family Smoking Prevention and Tobacco Control Act granted the FDA the authority to regulate and restrict tobacco advertising tactics that inaccurately convey reduced product risk, yet there is a dearth of up-to-date regulatory science to inform such regulations. Although the FDA has restricted use of descriptors such as "natural" and "additive-free," research shows that the tobacco industry quickly pivoted to increase use of alternative, unregulated tactics. Greenwashing is one increasingly common tobacco marketing strategy in which products are portrayed as eco-friendly and/or natural. The investigators' preliminary research indicates that greenwashing tactics may inaccurately convey modified product risk to consumers. The overarching objective of this project is to test the effect of greenwashing methods used by cigarette companies to market products on actual smoking behavior in a controlled laboratory study. The investigators' proposed research focuses on young adults (age 18-29), because this is a key age for smoking initiation and escalation, and research has found that young adults may be more susceptible than older adults to greenwashing in cigarette ads. This study will test the effect of greenwashing on behavioral economic demand and smoking topography in a laboratory-controlled cigarette self-administration study. These data will clearly connect tobacco advertising features to product risk perceptions and actual smoking behavior. This work will provide FDA with an integrated set of evidence that identifies misleading greenwashing tactics that inaccurately convey modified product risk which can be used to inform regulatory action regarding restrictions of this type of advertising.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 14, 2020
CompletedFirst Posted
Study publicly available on registry
October 20, 2020
CompletedStudy Start
First participant enrolled
August 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 22, 2024
CompletedResults Posted
Study results publicly available
June 15, 2025
CompletedJune 15, 2025
May 1, 2025
2.6 years
October 14, 2020
April 7, 2025
May 22, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Demand Intensity as Assessed by a Behavioral Economic Demand Curve
Number of cigarette puff bouts smoked at no cost as measured by a demand curve
Through study completion, an average of 2 weeks
Demand Elasticity as Assessed by a Behavioral Economic Demand Curve
Sensitivity of cigarette consumption to changes in cost for cigarettes
Through study completion, an average of 2 weeks
Cross-price Elasticity Coefficients as Assessed by a Behavioral Economic Demand Curve
Sensitivity of cigarette consumption to changes in cost for alternative products as a linear slope.
Through study completion, an average of 2 weeks
Change in Total Puff Volume as Measured by a Smoking Topography Machine
Total cigarette puff volume in milliliters (mls)
Days 2 and 3
Study Arms (1)
Smoking sessions
EXPERIMENTALThis is the single arm that will go through cigarette smoking sessions
Interventions
Participants undergo topography and behavioral economic sessions where they can make choices to earn cigarette puffs by pulling plungers on experimental equipment
Eligibility Criteria
You may qualify if:
- Age 18 - 29 years of age
- Smoke at least five cigarettes per day
- Have an expired carbon monoxide level of more than 8 ppm or a urinary cotinine level of more than 100 ng per milliliter
You may not qualify if:
- The intention to quit smoking in the next 30 days
- Report "roll your own" cigarettes as an exclusive form of smoking
- A serious medical or psychiatric disorder or unstable condition
- Any positive toxicological screening for illicit drugs other than cannabis will be excluded
- Women who are pregnant, plan to become pregnant or are breast-feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Behavioral Pharmacology Research Unit
Baltimore, Maryland, 21224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Matthew Johnson
- Organization
- Johns Hopkins University
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew W Johnson, Ph.D.
Professor
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 14, 2020
First Posted
October 20, 2020
Study Start
August 18, 2021
Primary Completion
March 22, 2024
Study Completion
March 22, 2024
Last Updated
June 15, 2025
Results First Posted
June 15, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share